Sustained testosterone suppression: prognostic indicator in advanced hormone sensitive prostate cancer
Sustained testosterone suppression provides a clinically applicable method for assessing treatment efficacy and predicting prognosis in aHSPC.
Authors
- Xin Huang (ORCID: https://orcid.org/0000-0002-0413-3340)
- Tao Zhuo (ORCID: https://orcid.org/0000-0001-8860-1887)
- Dongsheng Ma (ORCID: https://orcid.org/0009-0001-4708-186X)
- Jianying Xi (ORCID: https://orcid.org/0000-0003-1028-3801)
Institutions
- Xinjiang Medical University (CN)
- Chongqing University (CN)
- Fifth Affiliated Hospital of Xinjiang Medical University (CN)
- First Affiliated Hospital of Xinjiang Medical University (CN)
- Bozhou People's Hospital (CN)
- Chongqing Emergency Medical Center (CN)
Publication Details
- Journal
- Frontiers in Endocrinology
- Published
- 2025-10-13
- DOI
- https://doi.org/10.3389/fendo.2025.1652941
- Primary Topic
- Prostate Cancer Treatment and Research
- Type
- article
- Field-Weighted Citation Impact
- 0.00